(Q42506998)

1 November 2017

Second malignancies in melanoma patients in Thuringia (English)

1 reference

1 November 2017

Wolff J

1

1 reference

PubMed ID

11444270

1 November 2017

Wollina U

series ordinal

2

1 reference

1 November 2017

1 November 2000

1 reference

Journal of the European Academy of Dermatology and Venereology

1 November 2017

1 reference

1 November 2017

14

1 reference

1 November 2017

6

1 reference

1 November 2017

479-483

1 reference

Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry

1 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Incidence of invasive cancers following cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Are malignant melanoma patients at higher risk for a second cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Cutaneous malignant melanomas with other coexisting neoplasms: a true association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Multiple primary melanoma - a review of 90 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Multiple Primary Cutaneous Melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Attributes and survival patterns of multiple primary cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Overexpression and mutations of p53 in metastatic malignant melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

Genetic predisposition to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00162.X

10.1046/J.1468-3083.2000.00162.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference

PubMed ID

11444270